
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Exploring Combined Use of Continuous Glucose Monitoring and Anti‐Diabetes Medications on Glycaemic Control for People With Type 2 Diabetes Not Using Insulin - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4838B8AEEF72305838B00394D25A3.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="edm">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375899/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Endocrinology, Diabetes &amp; Metabolism">
<meta name="citation_title" content="Exploring Combined Use of Continuous Glucose Monitoring and Anti‐Diabetes Medications on Glycaemic Control for People With Type 2 Diabetes Not Using Insulin">
<meta name="citation_author" content="Poorva M Nemlekar">
<meta name="citation_author_institution" content="Health Economics and Outcomes Research, Clinical Affairs, Dexcom, Inc. San Diego, California, USA">
<meta name="citation_author" content="Katia L Hannah">
<meta name="citation_author_institution" content="Health Economics and Outcomes Research, Clinical Affairs, Dexcom, Inc. San Diego, California, USA">
<meta name="citation_author" content="Courtney R Green">
<meta name="citation_author_institution" content="Medical Affairs, Dexcom, Inc. San Diego, California, USA">
<meta name="citation_author" content="Gregory J Norman">
<meta name="citation_author_institution" content="Health Economics and Outcomes Research, Clinical Affairs, Dexcom, Inc. San Diego, California, USA">
<meta name="citation_publication_date" content="2025 Aug 25">
<meta name="citation_volume" content="8">
<meta name="citation_issue" content="5">
<meta name="citation_firstpage" content="e70089">
<meta name="citation_doi" content="10.1002/edm2.70089">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375899/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375899/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375899/pdf/EDM2-8-e70089.pdf">
<meta name="description" content="Continuous glucose monitoring (CGM) offers a detailed view of glycaemic management, potentially enhancing the effectiveness of non‐insulin, anti‐diabetes medications. This study aimed to evaluate whether CGM use in combination with anti‐diabetes ...">
<meta name="og:title" content="Exploring Combined Use of Continuous Glucose Monitoring and Anti‐Diabetes Medications on Glycaemic Control for People With Type 2 Diabetes Not Using Insulin">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Continuous glucose monitoring (CGM) offers a detailed view of glycaemic management, potentially enhancing the effectiveness of non‐insulin, anti‐diabetes medications. This study aimed to evaluate whether CGM use in combination with anti‐diabetes ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375899/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12375899">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/edm2.70089"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/EDM2-8-e70089.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12375899%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12375899/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12375899/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375899/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-edm.jpg" alt="Endocrinology, Diabetes &amp; Metabolism logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Endocrinology, Diabetes &amp; Metabolism" title="Link to Endocrinology, Diabetes &amp; Metabolism" shape="default" href="https://onlinelibrary.wiley.com/journal/23989238" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Endocrinol Diabetes Metab</button></div>. 2025 Aug 25;8(5):e70089. doi: <a href="https://doi.org/10.1002/edm2.70089" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/edm2.70089</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Endocrinol%20Diabetes%20Metab%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Endocrinol%20Diabetes%20Metab%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Endocrinol%20Diabetes%20Metab%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Endocrinol%20Diabetes%20Metab%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Exploring Combined Use of Continuous Glucose Monitoring and Anti‐Diabetes Medications on Glycaemic Control for People With Type 2 Diabetes Not Using Insulin</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nemlekar%20PM%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Poorva M Nemlekar</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Poorva M Nemlekar</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Health Economics and Outcomes Research, Clinical Affairs, Dexcom, Inc. San Diego, California, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nemlekar%20PM%22%5BAuthor%5D" class="usa-link"><span class="name western">Poorva M Nemlekar</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hannah%20KL%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Katia L Hannah</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Katia L Hannah</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Health Economics and Outcomes Research, Clinical Affairs, Dexcom, Inc. San Diego, California, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hannah%20KL%22%5BAuthor%5D" class="usa-link"><span class="name western">Katia L Hannah</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Green%20CR%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Courtney R Green</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Courtney R Green</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Medical Affairs, Dexcom, Inc. San Diego, California, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Green%20CR%22%5BAuthor%5D" class="usa-link"><span class="name western">Courtney R Green</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Norman%20GJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Gregory J Norman</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Gregory J Norman</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Health Economics and Outcomes Research, Clinical Affairs, Dexcom, Inc. San Diego, California, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Norman%20GJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Gregory J Norman</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="edm270089-aff-0001">
<sup>
<sup>1</sup>
</sup>Health Economics and Outcomes Research, Clinical Affairs, Dexcom, Inc. San Diego, California, USA</div>
<div id="edm270089-aff-0002">
<sup>
<sup>2</sup>
</sup>Medical Affairs, Dexcom, Inc. San Diego, California, USA</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Gregory J. Norman (<span>greg.norman@dexcom.com</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jun 14; Received 2025 Mar 8; Accepted 2025 Jul 26; Collection date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Endocrinology, Diabetes &amp; Metabolism</em> published by John Wiley &amp; Sons Ltd.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12375899</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="edm270089-sec-0001"><h3 class="pmc_sec_title">Introduction</h3>
<p>Continuous glucose monitoring (CGM) offers a detailed view of glycaemic management, potentially enhancing the effectiveness of non‐insulin, anti‐diabetes medications. This study aimed to evaluate whether CGM use in combination with anti‐diabetes medications is associated with changes in A1c among people with type 2 diabetes not using insulin.</p></section><section id="edm270089-sec-0002"><h3 class="pmc_sec_title">Materials and Methods</h3>
<p>This was a retrospective, observational analysis of administrative claims and linked laboratory data from Optum's Clinformatics Data Mart database. The study observation period covered 01/07/2018 through 30/06/2023 with 6‐month baseline and follow‐up periods. CGM use in conjunction with ≥ 1 of five anti‐diabetes medication classes: metformin, sulfonylureas, sodium‐glucose cotransporter‐2 (SGLT2) inhibitors, dipeptidyl peptidase‐4 (DPP‐4) inhibitors and/or glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) was required. The primary outcome was change in A1c from baseline. Linear regression models tested the main and interaction effects of CGM and each anti‐diabetes medication.</p></section><section id="edm270089-sec-0003"><h3 class="pmc_sec_title">Results</h3>
<p>Overall, 52,394 CGM‐naïve adults with non‐insulin‐treated type 2 diabetes using anti‐diabetes medications were identified (4086 CGM users; 48,308 CGM non‐users). CGM use was associated with a –0.45% greater A1c change among CGM users compared to CGM non‐users (<em>p</em> &lt; 0.0001). After adjusting for covariates, CGM users experienced greater A1c reductions vs. CGM non‐users with all medications, but statistically significant interactions showed that for DPP‐4 inhibitors, GLP‐1 RAs and sulfonylureas, there were greater decreases in A1c for CGM users vs. CGM non‐users who were taking the medication compared to CGM users vs. CGM non‐users who were not taking the medication. A1c change between CGM users vs. CGM non‐users did not vary by metformin or SGLT2 inhibitor use.</p></section><section id="edm270089-sec-0004"><h3 class="pmc_sec_title">Discussion</h3>
<p>The findings suggest that CGM use could augment the glycaemic benefits of anti‐diabetes medications in people with non‐insulin treated type 2 diabetes. These results support broader adoption of CGM.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> continuous glucose monitoring, diabetes mellitus, GLP‐1 receptor agonist, non‐insulin therapy, type 2</p></section></section><section class="abstract" id="abstract2"><hr class="headless">
<p>In regression models, a significant interaction was found between continuous glucose monitoring (CGM) use and use of 3 anti‐diabetes medication classes: sulfonylureas, DPP‐4 inhibitors and GLP‐1 RAs. This synergistic effect means that CGM could augment the glycaemic benefits of anti‐diabetes medications in people with T2D not using insulin.</p>
<section class="bt xbox font-sm" id="edm270089-blkfxd-0001"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a9d/12375899/3fc986af7416/EDM2-8-e70089-g001.jpg" loading="lazy" id="jats-graphic-1" height="313" width="331" alt="graphic file with name EDM2-8-e70089-g001.jpg"></p></section></section><section id="edm270089-sec-0005"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>People living with type 2 diabetes are often prescribed multiple non‐insulin anti‐diabetes medications, such as metformin, sulfonylureas, sodium‐glucose cotransporter‐2 (SGLT2) inhibitors, dipeptidyl peptidase‐4 (DPP‐4) inhibitors and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) [<a href="#edm270089-bib-0001" class="usa-link" aria-describedby="edm270089-bib-0001">1</a>]. Increasingly, many are also using continuous glucose monitoring (CGM) systems to monitor their glucose levels and guide lifestyle modifications [<a href="#edm270089-bib-0002" class="usa-link" aria-describedby="edm270089-bib-0002">2</a>, <a href="#edm270089-bib-0003" class="usa-link" aria-describedby="edm270089-bib-0003">3</a>, <a href="#edm270089-bib-0004" class="usa-link" aria-describedby="edm270089-bib-0004">4</a>]. CGM access whether by insurance coverage expansion or the availability of lower‐cost, over‐the‐counter options is expected to increase the number of people with type 2 diabetes using non‐insulin medications and CGM.</p>
<p>CGM provides a more granular view of glycaemic management compared to volitional fingerstick blood glucose or periodic glycated haemoglobin (A1c) measurements. The data from CGM systems can be retrospectively analysed using web‐ or app‐based software, and the results can be interpreted by individual users, their healthcare providers and clinical researchers [<a href="#edm270089-bib-0005" class="usa-link" aria-describedby="edm270089-bib-0005">5</a>, <a href="#edm270089-bib-0006" class="usa-link" aria-describedby="edm270089-bib-0006">6</a>, <a href="#edm270089-bib-0007" class="usa-link" aria-describedby="edm270089-bib-0007">7</a>]. Studies have shown that CGM use helps lower A1c among people with type 2 diabetes using intensive insulin therapy (i.e., multiple daily injections or insulin pumps) [<a href="#edm270089-bib-0002" class="usa-link" aria-describedby="edm270089-bib-0002">2</a>, <a href="#edm270089-bib-0008" class="usa-link" aria-describedby="edm270089-bib-0008">8</a>, <a href="#edm270089-bib-0009" class="usa-link" aria-describedby="edm270089-bib-0009">9</a>] or basal insulin therapy [<a href="#edm270089-bib-0002" class="usa-link" aria-describedby="edm270089-bib-0002">2</a>, <a href="#edm270089-bib-0009" class="usa-link" aria-describedby="edm270089-bib-0009">9</a>, <a href="#edm270089-bib-0010" class="usa-link" aria-describedby="edm270089-bib-0010">10</a>, <a href="#edm270089-bib-0011" class="usa-link" aria-describedby="edm270089-bib-0011">11</a>, <a href="#edm270089-bib-0012" class="usa-link" aria-describedby="edm270089-bib-0012">12</a>]. Recently, more studies have explored the benefits of CGM among people with type 2 diabetes not using insulin [<a href="#edm270089-bib-0002" class="usa-link" aria-describedby="edm270089-bib-0002">2</a>, <a href="#edm270089-bib-0009" class="usa-link" aria-describedby="edm270089-bib-0009">9</a>, <a href="#edm270089-bib-0011" class="usa-link" aria-describedby="edm270089-bib-0011">11</a>, <a href="#edm270089-bib-0012" class="usa-link" aria-describedby="edm270089-bib-0012">12</a>, <a href="#edm270089-bib-0013" class="usa-link" aria-describedby="edm270089-bib-0013">13</a>].</p>
<p>As the variety of effective medications available for people with type 2 diabetes has reached an all‐time high, we hypothesised that CGM use could provide additional support and help those using anti‐diabetes medications improve their glycaemia. Therefore, we evaluated whether use of CGM in combination with five classes of anti‐diabetes medications was associated with changes in A1c among people with type 2 diabetes not using insulin.</p></section><section id="edm270089-sec-0006"><h2 class="pmc_sec_title">2. Materials and Methods</h2>
<section id="edm270089-sec-0007"><h3 class="pmc_sec_title">2.1. Data Source</h3>
<p>This retrospective, observational, database study used de‐identified administrative health claims and linked laboratory data from Optum's Clinformatics Data Mart (CDM) database. The CDM contains de‐identified health information consistent with the Health Insurance Portability and Accountability Act and managed according to Optum customer data use agreements in compliance with Code of Federal Regulations title 45, section 164.514 (b) (1) [<a href="#edm270089-bib-0014" class="usa-link" aria-describedby="edm270089-bib-0014">14</a>]. CDM administrative claims submitted for payment by HCPs and pharmacies are verified, adjudicated and de‐identified prior to inclusion. These data, including patient‐level enrolment information, are derived from claims submitted for all medical and pharmacy health care services with information related to health care costs and resource utilisation.</p></section><section id="edm270089-sec-0008"><h3 class="pmc_sec_title">2.2. Study Design and Cohort Selection</h3>
<p>The population included adults ≥ 30 years of age with type 2 diabetes identified using the International Classification of Diseases, 9th/10th Revisions (ICD‐9/ICD‐10) who were enrolled in commercial health plans, including Medicare Advantage health plans. The minimum age of 30 years for study inclusion is consistent with prior studies and is intended to reduce the likelihood of including individuals with type 1 diabetes and/or extensive comorbidities [<a href="#edm270089-bib-0015" class="usa-link" aria-describedby="edm270089-bib-0015">15</a>, <a href="#edm270089-bib-0016" class="usa-link" aria-describedby="edm270089-bib-0016">16</a>]. The study observation period covered 01/07/2018 through 30/06/2023. Type 2 diabetes diagnosis was confirmed with ≥ 1 inpatient hospital or emergency department medical claim or ≥ 2 ambulatory medical claims ≥ 30 and ≤ 730 days apart with an ICD‐9 or ICD‐10 diagnosis code for diabetes in any position on the claim during the study observation period [<a href="#edm270089-bib-0017" class="usa-link" aria-describedby="edm270089-bib-0017">17</a>].</p>
<p>Individuals with ≥ 1 CGM‐related claim identified through National Drug Codes or Healthcare Common Procedure Coding System codes (Table <a href="#edm270089-supitem-0003" class="usa-link">S1</a>) between 01/01/2019 and 31/12/2022 (study identification period) were included in the analysis. The index date was set as the earliest observed claim for any CGM system, including real‐time CGM and intermittently‐scanned CGM. For the cohort of CGM non‐users, a random index date mirroring the range and distribution of the index dates for CGM initiation in the CGM user cohort was selected. Individuals were required to have continuous health plan enrolment with medical and pharmacy coverage 6 months before (baseline) and 6 months after (follow‐up) the index date. Five classes of anti‐diabetes medications were included: metformin, sulfonylureas, SGLT2 inhibitors, DPP‐4 inhibitors and GLP‐1 RAs (Appendix <a href="#edm270089-supitem-0001" class="usa-link">S1</a>). A person was considered a medication user if there was ≥ 1 pharmacy claim for the medication present during both the baseline and the follow‐up periods. Exclusion criteria included evidence of pregnancy during the study period and claims for a personal CGM before the index date (subjects were CGM‐naïve). Individuals with evidence of basal, bolus or mixed insulin during baseline were excluded. Finally, individuals were required to have ≥ 1 laboratory A1c test result during the baseline period and ≥ 1 A1c laboratory test value during the follow‐up period. A mean baseline A1c ≥ 8.0% was required for study inclusion.</p></section><section id="edm270089-sec-0009"><h3 class="pmc_sec_title">2.3. Outcome Measures</h3>
<p>The primary outcome measure was change in A1c determined from the average of available A1c values during the baseline and follow‐up periods. Change in A1c was computed as the average A1c follow‐up value minus the average A1c baseline value, with negative values indicating improvement in A1c.</p></section><section id="edm270089-sec-0010"><h3 class="pmc_sec_title">2.4. Statistical Analyses</h3>
<p>The study specifically assessed whether the effect of CGM use on A1c change varied depending on the use of anti‐diabetes medication. General linear regression models were employed to assess the relationships between the independent variables (CGM use and anti‐diabetes medication use) and the dependent variable (A1c change) controlling for covariates (age, race, gender, insurance type, baseline A1c, Charlson comorbidity score and the presence of other medications). Each model tested the main effect and the interaction effect (i.e., effect modification) of CGM and each anti‐diabetes medication class. Each model also included an interaction term defined as the two‐way interaction between CGM use and anti‐diabetes medication use. Estimated marginal means (e‐means) from the regression models were used to display the A1c change at each level of the two‐way interaction.</p></section></section><section id="edm270089-sec-0011"><h2 class="pmc_sec_title">3. Results</h2>
<section id="edm270089-sec-0012"><h3 class="pmc_sec_title">3.1. Cohort Characteristics</h3>
<p>From a starting population of over 10 million individuals, nearly 4.3 million people were identified as ≥ 30 years of age and living with type 2 diabetes. After applying all inclusion and exclusion criteria, 52,394 people with type 2 diabetes using non‐insulin therapies were identified. Ultimately, 4086 were CGM users and 48,308 were CGM non‐users. Baseline demographic information for each cohort is presented in Table <a href="#edm270089-tbl-0001" class="usa-link">1</a>. During the follow‐up period, 46.7% of CGM users and 43.3% of CGM non‐users achieved a mean A1c that met the Healthcare Effectiveness Data and Information Set (HEDIS) target of &lt; 8.0% (<em>p</em> &lt; 0.0001 between groups).</p>
<section class="tw xbox font-sm" id="edm270089-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Baseline demographic and health characteristics.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Characteristic</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">CGM users</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">CGM non‐users</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">
<em>N</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">4086</td>
<td align="center" valign="top" rowspan="1" colspan="1">48,308</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age, mean (SD)</td>
<td align="center" valign="top" rowspan="1" colspan="1">67.5 (10.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">67.0 (10.9)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Male</td>
<td align="center" valign="top" rowspan="1" colspan="1">2130 (52.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">26,622 (55.1)</td>
</tr>
<tr><td align="left" colspan="3" valign="top" rowspan="1">Race</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Asian</td>
<td align="center" valign="top" rowspan="1" colspan="1">135 (3.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2466 (5.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Black</td>
<td align="center" valign="top" rowspan="1" colspan="1">572 (14.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6139 (13.6)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hispanic</td>
<td align="center" valign="top" rowspan="1" colspan="1">438 (11.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9524 (21.1)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">White</td>
<td align="center" valign="top" rowspan="1" colspan="1">2682 (69.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">26,332 (58.3)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Unknown</td>
<td align="center" valign="top" rowspan="1" colspan="1">44 (1.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">705 (1.6)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Missing/not reported</td>
<td align="center" valign="top" rowspan="1" colspan="1">215 (5.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3142 (6.5)</td>
</tr>
<tr><td align="left" colspan="3" valign="top" rowspan="1">Region</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Midwest</td>
<td align="center" valign="top" rowspan="1" colspan="1">788 (19.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7649 (15.8)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Northeast</td>
<td align="center" valign="top" rowspan="1" colspan="1">477 (11.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4820 (10.0)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">South</td>
<td align="center" valign="top" rowspan="1" colspan="1">2138 (52.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25,238 (52.2)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">West</td>
<td align="center" valign="top" rowspan="1" colspan="1">683 (16.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,591 (21.9)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Baseline A1c, %, mean (SD)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.46 (1.30)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.16 (1.18)</td>
</tr>
<tr><td align="left" colspan="3" valign="top" rowspan="1">Insurance type</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Medicare Advantage</td>
<td align="center" valign="top" rowspan="1" colspan="1">3484 (85.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">36,982 (76.6)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Commercial</td>
<td align="center" valign="top" rowspan="1" colspan="1">602 (14.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11,326 (23.4)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Charlson comorbidity score, mean (SD)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.02 (1.89)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.29 (1.55)</td>
</tr>
<tr><td align="left" colspan="3" valign="top" rowspan="1">Comorbidities</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Chronic kidney disease</td>
<td align="center" valign="top" rowspan="1" colspan="1">1004 (24.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6411 (13.3)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Congestive heart failure</td>
<td align="center" valign="top" rowspan="1" colspan="1">579 (14.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3691 (7.6)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Diabetic retinopathy</td>
<td align="center" valign="top" rowspan="1" colspan="1">864 (21.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4615 (9.6)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hyperlipidemia</td>
<td align="center" valign="top" rowspan="1" colspan="1">3359 (82.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35,712 (73.9)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hypertension</td>
<td align="center" valign="top" rowspan="1" colspan="1">3337 (81.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35,683 (73.9)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Myocardial infarction</td>
<td align="center" valign="top" rowspan="1" colspan="1">257 (6.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1590 (3.3)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Obesity</td>
<td align="center" valign="top" rowspan="1" colspan="1">1560 (38.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14,242 (29.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Peripheral neuropathy</td>
<td align="center" valign="top" rowspan="1" colspan="1">1575 (38.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,217 (21.1)</td>
</tr>
<tr><td align="left" colspan="3" valign="top" rowspan="1">Medication use</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">DPP‐4 inhibitor</td>
<td align="center" valign="top" rowspan="1" colspan="1">180 (4.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6582 (13.6)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">GLP‐1 RA</td>
<td align="center" valign="top" rowspan="1" colspan="1">657 (16.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7633 (15.8)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Metformin</td>
<td align="center" valign="top" rowspan="1" colspan="1">1341 (32.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">31,946 (66.1)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">SGLT2 inhibitor</td>
<td align="center" valign="top" rowspan="1" colspan="1">451 (11.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8316 (17.2)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Sulfonylurea</td>
<td align="center" valign="top" rowspan="1" colspan="1">689 (16.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">21,478 (44.5)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/edm270089-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="edm270089-note-0002"><p>
<em>Note:</em> Data are <em>n</em> (%) unless noted otherwise. A <em>t</em> test or chi‐squared test was used to assess statistically significant differences between groups. All comparisons were statistically significant at <em>p</em> &lt; 0.01 except GLP‐1 RA use at <em>p</em> = 0.66.</p></div>
<div class="fn" id="edm270089-note-0003"><p>Abbreviations: DPP‐4, dipeptidyl peptidase‐4; GLP‐1 RA, glucagon‐like peptide‐1 receptor agonist; SGLT2, sodium‐glucose cotransporter‐2.</p></div>
</div></section></section><section id="edm270089-sec-0013"><h3 class="pmc_sec_title">3.2. Interaction of CGM and Medications</h3>
<p>The univariate unadjusted main effect of CGM use was a −0.45% greater A1c change among CGM users compared to CGM non‐users (<em>p</em> &lt; 0.0001). After adjusting for covariates, A1c change among CGM users compared to CGM non‐users was attenuated (−0.28%) but remained statistically significant (<em>p</em> &lt; 0.0001, Table <a href="#edm270089-tbl-0002" class="usa-link">2</a>). This A1c change among CGM users was consistent across regression models (−0.26% to −0.27%, all <em>p</em> &lt; 0.0001, Tables <a href="#edm270089-tbl-0002" class="usa-link">S2</a>–<a href="#edm270089-supitem-0003" class="usa-link">S6</a>).</p>
<section class="tw xbox font-sm" id="edm270089-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Linear regression model without interaction terms with change in A1c as the outcome variable.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Covariate</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">ΔA1c, B (SE)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">95% CI</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>‐value</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">(Intercept)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.89 (0.07)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[4.75, 5.03]</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">CGM use</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.28 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[−0.33, −0.23]</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age at index</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.00 (0.00)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[0.00, 0.00]</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">A1c at baseline</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.60 (0.01)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[−0.61, −0.59]</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Race: Asian<sup>a</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.04 (0.03)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[−0.01, 0.10]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.12</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Race: Black<sup>a</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.13 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[0.09, 0.16]</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Race: Hispanic<sup>a</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.18 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[0.15, 0.21]</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Race: Unknown<sup>a</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.14 (0.05)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[0.04, 0.24]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.004</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Insurance type: Medicare Advantage<sup>b</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.10 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[0.06, 0.13]</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Gender: Male</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.05 (0.01)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[−0.07, −0.02]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0002</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Charlson comorbidity score at baseline</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.02 (0.00)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[−0.03, −0.01]</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Metformin use<sup>c</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.21 (0.01)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[−0.23, −0.18]</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Sulfonylurea use<sup>c</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.15 (0.01)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[0.12, 0.17]</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">SGLT2 inhibitor use<sup>c</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.02 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[−0.05, 0.01]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.22</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">DPP‐4 inhibitor use<sup>c</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.04 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[0.01, 0.08]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.02</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">GLP‐1 RA use<sup>c</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.18 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">[−0.22, −0.15]</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.0001</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/edm270089-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="edm270089-note-0005"><p>
<em>Note:</em>
<sup>a</sup>Reference race is White; <sup>b</sup>reference insurance type is commercial; <sup>c</sup>defined as use of medication at baseline and follow‐up.</p></div>
<div class="fn" id="edm270089-note-0004"><p>Abbreviations: CGM, continuous glucose monitoring; CI, confidence interval; DPP‐4, dipeptidyl peptidase‐4; GLP‐1 RA, glucagon‐like peptide‐1 receptor agonist; SE, standard error; SGLT2, sodium‐glucose cotransporter‐2.</p></div>
</div></section><p>Mean A1c at baseline was a significant predictor of A1c change at follow‐up. Specifically, each 1.0 percentage point increase in baseline A1c was associated with a 0.6 percentage point decrease in A1c between baseline and follow‐up (<em>p</em> &lt; 0.0001, Table <a href="#edm270089-tbl-0002" class="usa-link">2</a>). Similarly, metformin use (−0.21%) and GLP‐1 RA use (−0.18%) were associated with decreased A1c, whilst sulfonylurea use (0.15%) was associated with increased A1c (all <em>p</em> &lt; 0.0001).</p>
<p>Plots of the model‐based e‐means for the two‐way interactions of CGM with each medication class show CGM users experienced greater reductions in A1c (−0.95% to −1.31%) compared to CGM non‐users (−0.69% to −0.89%), regardless of anti‐diabetes medication class use (Figure <a href="#edm270089-supitem-0002" class="usa-link">S1</a>). Statistically significant interaction effects were observed for CGM with three medication classes: sulfonylureas, DPP‐4 inhibitors and GLP‐1 RAs (Tables <a href="#edm270089-supitem-0003" class="usa-link">S2</a>–<a href="#edm270089-supitem-0003" class="usa-link">S4</a>), indicating a greater decrease in A1c for CGM users vs. CGM non‐users who were taking the medication compared to CGM users vs. CGM non‐users who were not taking the medication.</p>
<p>Table <a href="#edm270089-tbl-0003" class="usa-link">3</a> shows the e‐means from the regression models for change in A1c between CGM users and CGM non‐users by medication and the corresponding two‐way interaction effect. CGM users experienced a greater decrease in A1c compared to CGM non‐users regardless of sulfonylurea use (Table <a href="#edm270089-tbl-0003" class="usa-link">3</a> and Figure <a href="#edm270089-supitem-0002" class="usa-link">S1A</a>). The change in A1c between CGM users and CGM non‐users was greater among sulfonylurea users (−1.10% vs. −0.71%, ΔA1c = −0.39%) compared to those not taking a sulfonylurea (−1.12% vs. −0.86%, ΔA1c = −0.26%), resulting in an estimated interaction effect of β = −0.13 (<em>p</em> &lt; 0.05) (Table <a href="#edm270089-tbl-0002" class="usa-link">S2</a>).</p>
<section class="tw xbox font-sm" id="edm270089-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Interaction table of estimated model means.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Parameter</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">CGM users, e‐mean (SE)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">CGM non‐users, e‐mean (SE)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<p>Difference in</p>
<p>ΔA1c</p>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>‐value</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Sulfonylurea use</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.10 (0.06)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.71 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.39</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">No sulfonylurea use</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.12 (0.03)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.86 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.26</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Interaction with CGM</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.13</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.031</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">DPP‐4 inhibitor use</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.31 (0.11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.76 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.55</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">No DPP‐4 inhibitor use</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.08 (0.03)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.81 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.27</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Interaction with CGM</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.28</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.009</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">GLP‐1 RA use</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.27 (0.06)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.87 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.40</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">No GLP‐1 RA use</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.95 (0.03)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.70 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.25</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Interaction with CGM</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.14</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.023</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Metformin use</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.20 (0.04)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.89 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.31</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">No metformin use</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.95 (0.03)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.69 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.26</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Interaction with CGM</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.05</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.35</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">SGLT2 inhibitor use</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.15 (0.07)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.80 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.35</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">No SGLT2 inhibitor use</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.05 (0.03)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.78 (0.02)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.27</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Interaction with CGM</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.08</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.27</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/edm270089-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="edm270089-note-0006"><p>Abbreviations: CGM, continuous glucose monitoring; DPP‐4, dipeptidyl peptidase‐4; GLP‐1 RA, glucagon‐like peptide‐1 receptor agonist; SE, standard error; SGLT2, sodium‐glucose cotransporter‐2.</p></div></div></section><p>The association of CGM use with change in A1c varied by DPP‐4 inhibitor use (Table <a href="#edm270089-tbl-0003" class="usa-link">3</a> and Figure <a href="#edm270089-supitem-0002" class="usa-link">S1B</a>) where change in A1c between CGM users and CGM non‐users was greater among DPP‐4 inhibitor users (−1.31% vs. −0.76%, ΔA1c = −0.55%) compared to those not taking a DPP‐4 inhibitor (−1.08% vs. −0.81%, ΔA1c = −0.27%) with an interaction effect of β = −0.28 (<em>p</em> &lt; 0.01) (Table <a href="#edm270089-tbl-0003" class="usa-link">3</a>).</p>
<p>Similarly, the association of CGM use with change in A1c varied by GLP‐1 RA use (Table <a href="#edm270089-tbl-0003" class="usa-link">3</a> and Figure <a href="#edm270089-supitem-0002" class="usa-link">S1C</a>). Whilst CGM users overall had a greater decrease in A1c compared to CGM non‐users, the change in A1c between CGM users and CGM non‐users was greater among GLP‐1 RA users (−1.27% vs. −0.87%, ΔA1c = −0.40%) compared to those not taking a GLP‐1 RA (−0.95% vs. −0.70%, ΔA1c = −0.25%) (interaction effect β = −0.14, <em>p</em> &lt; 0.05) (Table <a href="#edm270089-supitem-0003" class="usa-link">S4</a>).</p>
<p>Whilst there was a numerical difference in A1c change between CGM users and CGM non‐users among metformin users (−1.20% vs. −0.89%, ΔA1c = −0.31%) compared to those not taking metformin (−0.95% vs. −0.69%, ΔA1c = −0.26%), this difference was not statistically significant (β = −0.05, <em>p</em> = 0.37, Table <a href="#edm270089-tbl-0003" class="usa-link">3</a>, Table <a href="#edm270089-supitem-0003" class="usa-link">S5</a> and Figure <a href="#edm270089-supitem-0002" class="usa-link">S1D</a>).</p>
<p>Similarly, whilst there was a numerical difference in A1c change between CGM users and CGM non‐users among SGLT2 inhibitor users (−1.15% vs. −0.80%, ΔA1c = −0.35%) compared to those not taking SGLT2 inhibitors (−1.05% vs. −0.78%, ΔA1c = −0.27%), this difference was not statistically significant (β = −0.08, <em>p</em> = 0.27, Table <a href="#edm270089-tbl-0003" class="usa-link">3</a>, Table <a href="#edm270089-supitem-0003" class="usa-link">S6</a> and Figure <a href="#edm270089-supitem-0002" class="usa-link">S1E</a>).</p></section></section><section id="edm270089-sec-0014"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>In this retrospective, observational database study of people with type 2 diabetes using anti‐diabetes medications and, in some cases, CGM, use of CGM was associated with greater decreases in A1c compared to CGM non‐use. In addition, the findings suggest there was a synergistic effect of CGM in combination with sulfonylureas, DPP‐4 inhibitors and GLP‐1 RAs.</p>
<p>The observed synergistic effect between CGM use and certain anti‐diabetes medications is notable and, in fact, supports the American Diabetes Association's recent recommendation to consider CGM use among adults with type 2 diabetes treated with glucose‐lowering medications [<a href="#edm270089-bib-0004" class="usa-link" aria-describedby="edm270089-bib-0004">4</a>]. CGM use alongside anti‐diabetes medications could promote adherence to those medications because users are able to see their glycaemic effects. It is also possible that CGM users shared their data with their healthcare provider, who was able to adjust their medication dosage. Studies have shown that CGM use can reduce therapeutic inertia in clinical practice [<a href="#edm270089-bib-0018" class="usa-link" aria-describedby="edm270089-bib-0018">18</a>, <a href="#edm270089-bib-0019" class="usa-link" aria-describedby="edm270089-bib-0019">19</a>]. CGM use could have also motivated behaviour change [<a href="#edm270089-bib-0020" class="usa-link" aria-describedby="edm270089-bib-0020">20</a>, <a href="#edm270089-bib-0021" class="usa-link" aria-describedby="edm270089-bib-0021">21</a>, <a href="#edm270089-bib-0022" class="usa-link" aria-describedby="edm270089-bib-0022">22</a>], which drove additional reductions in A1c over medication use alone.</p>
<p>A consensus statement endorsed by multiple global organisations on the use of CGM in clinical trials [<a href="#edm270089-bib-0006" class="usa-link" aria-describedby="edm270089-bib-0006">6</a>] underscores its value in measuring the glycaemic impact of medical interventions. The ability to collect glucose data throughout the day and night and analyse an individual's response to food or drink choices, medication taking, physical activity, sleep and many other variables is unmatched. Glycaemic variability and the presence of dangerous hypoglycaemic or hyperglycaemic events can also be assessed with CGM, which A1c measurements, as an average of the previous 3 months of glycaemic control, cannot provide [<a href="#edm270089-bib-0023" class="usa-link" aria-describedby="edm270089-bib-0023">23</a>].</p>
<p>Compared with other studies of CGM use among people with type 2 diabetes not on insulin therapy, the A1c change described in this study was lower (−0.45% crude or −0.28% after adjusting for covariates) compared to −3.0% in Grace [<a href="#edm270089-bib-0012" class="usa-link" aria-describedby="edm270089-bib-0012">12</a>] and –1.6% in Wright [<a href="#edm270089-bib-0011" class="usa-link" aria-describedby="edm270089-bib-0011">11</a>]. However, both of these were single‐arm studies and used real‐time CGM and intermittently scanned CGM, respectively. Our result is in line with the −0.3% adjusted difference in Aronson et al. [<a href="#edm270089-bib-0013" class="usa-link" aria-describedby="edm270089-bib-0013">13</a>] which compared intermittently scanned CGM use and diabetes education to a control group who received diabetes education alone. In line with our study, these studies similarly required A1c values of ≥ 7.5% [<a href="#edm270089-bib-0012" class="usa-link" aria-describedby="edm270089-bib-0012">12</a>, <a href="#edm270089-bib-0013" class="usa-link" aria-describedby="edm270089-bib-0013">13</a>] or ≥ 8.0% [<a href="#edm270089-bib-0011" class="usa-link" aria-describedby="edm270089-bib-0011">11</a>]. Finally, a retrospective study of individuals receiving care from an American Medical Group Association (AMGA) member organisation found an A1c decrease of −1.13% among people with type 2 diabetes not on insulin therapy with a baseline A1c ≥ 7.5% [<a href="#edm270089-bib-0009" class="usa-link" aria-describedby="edm270089-bib-0009">9</a>]. Whilst these comparisons are important to contextualise the findings of this study related to A1c, the aim of this study was to assess the interactions between CGM use and anti‐diabetes medication use.</p>
<p>The synergistic effect described here between CGM and GLP‐1 RA use has been described elsewhere. Wright et al. found that the combined use of CGM and a GLP‐1 RA among people with type 2 diabetes was associated with larger decreases in A1c compared to GLP‐1 RA use alone [<a href="#edm270089-bib-0024" class="usa-link" aria-describedby="edm270089-bib-0024">24</a>]. Miller et al. described significant A1c improvements among people with suboptimally controlled type 2 diabetes following the addition of CGM to prior GLP‐1 RA therapy [<a href="#edm270089-bib-0025" class="usa-link" aria-describedby="edm270089-bib-0025">25</a>]. Finally, Ehrhardt et al. and Parsiani et al. [<a href="#edm270089-bib-0026" class="usa-link" aria-describedby="edm270089-bib-0026">26</a>] described the use of CGM to titrate medications, including GLP‐1 RA therapies, in clinical practice [<a href="#edm270089-bib-0027" class="usa-link" aria-describedby="edm270089-bib-0027">27</a>].</p>
<p>Strengths of our study include the large study population, the use of a major administrative claims database and the analysis of five different classes of anti‐diabetes medications. Multivariate regression models were adjusted for factors that may influence glycaemia, including baseline A1c and the presence of other anti‐diabetes medications. This allowed us to isolate the combined effect of CGM with each medication class.</p>
<p>There were some notable differences between groups, including a higher proportion of Hispanics, a lower Charlson comorbidity score and higher rates of anti‐diabetes medication use among CGM non‐users, compared to CGM users. These differences, especially the higher rates of CGM non‐use among historically marginalised groups, are the subject of considerable research [<a href="#edm270089-bib-0028" class="usa-link" aria-describedby="edm270089-bib-0028">28</a>, <a href="#edm270089-bib-0029" class="usa-link" aria-describedby="edm270089-bib-0029">29</a>, <a href="#edm270089-bib-0030" class="usa-link" aria-describedby="edm270089-bib-0030">30</a>], and these characteristics were all included as covariates in our regression model.</p>
<p>The complexity of type 2 diabetes and its progressive nature may necessitate polypharmacy to achieve an individual's health goals [<a href="#edm270089-bib-0031" class="usa-link" aria-describedby="edm270089-bib-0031">31</a>]. Whilst our analysis attempted to control for other medication use, the large number of combination medications (Appendix <a href="#edm270089-supitem-0001" class="usa-link">S1</a>), including combinations with medications not assessed in this study (e.g., thiazolidinediones), limited our ability to isolate specific medication effects. It is important to note that the effectiveness of a medication may depend on other factors such as the duration of diabetes and the potency of a medication in the presence of other medications. For example, polypharmacy could have attenuated the glycaemic effects of some medications, including DPP‐4 inhibitors [<a href="#edm270089-bib-0032" class="usa-link" aria-describedby="edm270089-bib-0032">32</a>] and sulfonylureas.</p>
<p>Other limitations of this study include the all‐US population with a high baseline A1c (≥ 8.0%), which limits generalisability to other countries or more well‐controlled populations. In addition, Optum's CDM database only includes medical claims from commercial insurers (including Medicare Advantage), which could limit generalisability to those on Medicaid or traditional Medicare insurance plans. Whilst our study protocol was not prospectively registered, this retrospective, observational study was exploratory in nature. The study period included the COVID‐19 pandemic, which could have influenced both medication taking and lifestyle factors like food intake or physical activity. In addition, some medications, particularly GLP‐1 RAs, were subject to shortages during our study period [<a href="#edm270089-bib-0033" class="usa-link" aria-describedby="edm270089-bib-0033">33</a>], which could have impacted user adherence to their medication. Medication or CGM adherence can impact therapy effectiveness [<a href="#edm270089-bib-0034" class="usa-link" aria-describedby="edm270089-bib-0034">34</a>, <a href="#edm270089-bib-0035" class="usa-link" aria-describedby="edm270089-bib-0035">35</a>]; however, user adherence to therapies was not assessed in this study. Our analyses were limited to medical and pharmacy claims with linked laboratory data, which do not include potentially important information such as duration of diabetes, health awareness or educational level. We did not consider the presence of other non‐diabetes medications or differentiate anti‐diabetes medications by strength or dosage. For example, our study included multiple available GLP‐1 RAs (Appendix <a href="#edm270089-supitem-0001" class="usa-link">S1</a>), which could have significantly different impacts on A1c.</p></section><section id="edm270089-sec-0015"><h2 class="pmc_sec_title">5. Conclusions</h2>
<p>These findings suggest that CGM may be effective for improving glycaemic control among people with type 2 diabetes not using insulin when used alone or in combination with anti‐diabetes medications. Greater access to CGM may help more people learn about their diabetes, the medications they are prescribed and their role in managing their health status.</p></section><section id="edm270089-sec-0016"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>
<strong>P.M.N.:</strong> conceptualisation; data curation; formal analysis; methodology; visualisation; writing – review and editing. <strong>K.L.H.:</strong> conceptualisation; methodology; writing – review and editing. <strong>C.R.G.:</strong> visualisation; writing – original draft preparation; writing – review and editing. <strong>G.J.N.:</strong> conceptualisation; methodology; supervision; visualisation; writing – review and editing. All authors approved the final version of the manuscript.</p></section><section id="edm270089-sec-0017"><h2 class="pmc_sec_title">Disclosure</h2>
<p>Prior Presentation: Portions of this article were presented at the 84th Scientific Sessions of the American Diabetes Association held in Orlando, Florida on 20–23 June 2024.</p></section><section id="edm270089-sec-0018"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>All authors are employees of Dexcom Inc.</p></section><section id="sec19"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="edm270089-supitem-0001"><div class="caption p"><p>
<strong>Appendix S1:</strong> National drug codes for anti‐diabetes medications.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12375899/bin/EDM2-8-e70089-s002.xlsx" data-ga-action="click_feat_suppl" class="usa-link">EDM2-8-e70089-s002.xlsx</a><sup> (138.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="edm270089-supitem-0002"><div class="caption p"><p>
<strong>Figure S1:</strong> Change in A1c by CGM use and use of anti‐diabetes medication.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12375899/bin/EDM2-8-e70089-s003.pdf" data-ga-action="click_feat_suppl" class="usa-link">EDM2-8-e70089-s003.pdf</a><sup> (8.6KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="edm270089-supitem-0003"><div class="caption p">
<p>
<strong>Table S1:</strong> National drug codes (NDCs) and healthcare common procedure coding system (HCPCS) codes for CGM systems included in the analysis.</p>
<p>
<strong>Table S2:</strong> Linear regression model including the two‐way interaction term for CGM use and sulfonylurea use.</p>
<p>
<strong>Table S3:</strong> Linear regression model including the two‐way interaction term for CGM use and DPP‐4 inhibitor use.</p>
<p>
<strong>Table S4:</strong> Linear regression model including the two‐way interaction term for CGM use and GLP‐1 RA use.</p>
<p>
<strong>Table S5:</strong> Linear regression model including the two‐way interaction term for CGM use and metformin use.</p>
<p>
<strong>Table S6:</strong> Linear regression model including the two‐way interaction term for CGM use and SGLT2 inhibitor use.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12375899/bin/EDM2-8-e70089-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">EDM2-8-e70089-s001.docx</a><sup> (51.3KB, docx) </sup>
</div></div></section></section><section id="notes1"><p>

Nemlekar P. M., Hannah K. L., Green C. R., and Norman G. J., “Exploring Combined Use of Continuous Glucose Monitoring and Anti‐Diabetes Medications on Glycaemic Control for People With Type 2 Diabetes Not Using Insulin,” Endocrinology, Diabetes &amp; Metabolism
8, no. 5 (2025): e70089, 10.1002/edm2.70089.
</p>
<section id="edm270089-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="edm270089-note-0001"><p>
<strong>Funding:</strong> This work was supported by Dexcom.</p></div></div></section></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Poorva M. Nemlekar, Email: poorva.nemlekar@dexcom.com.</p>
<p>Katia L. Hannah, Email: katia.hannah@dexcom.com</p>
<p>Courtney R. Green, Email: courtney.green@dexcom.com.</p>
<p>Gregory J. Norman, Email: greg.norman@dexcom.com.</p></section><section id="edm270089-sec-0020"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The data that support the findings of this study are available from Optum. Restrictions apply to the availability of these data, which were used under license for this study. Data are available from the authors with the permission of Optum.</p></section><section id="edm270089-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="edm270089-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="edm270089-bib-0001">
<span class="label">1.</span><cite>
American Diabetes Association Professional Practice Committee
, “9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes‐2025,” Diabetes Care
48, no. Suppl_1 (2025): S181–S206.
</cite> [<a href="https://doi.org/10.2337/dc25-S009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11635045/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39651989/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=9.%20Pharmacologic%20Approaches%20to%20Glycemic%20Treatment:%20Standards%20of%20Care%20in%20Diabetes%E2%80%902025&amp;volume=48&amp;issue=Suppl_1&amp;publication_year=2025&amp;pages=S181-S206&amp;pmid=39651989&amp;doi=10.2337/dc25-S009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0002">
<span class="label">2.</span><cite>
Jackson M. A., Ahmann A., and Shah V. N., “Type 2 Diabetes and the Use of Real‐Time Continuous Glucose Monitoring,” Diabetes Technology &amp; Therapeutics
23, no. S1 (2021): S27–S34.
</cite> [<a href="https://doi.org/10.1089/dia.2021.0007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7957379/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33534631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Technology%20&amp;%20Therapeutics&amp;title=Type%202%20Diabetes%20and%20the%20Use%20of%20Real%E2%80%90Time%20Continuous%20Glucose%20Monitoring&amp;author=M.%20A.%20Jackson&amp;author=A.%20Ahmann&amp;author=V.%20N.%20Shah&amp;volume=23&amp;issue=S1&amp;publication_year=2021&amp;pages=S27-S34&amp;pmid=33534631&amp;doi=10.1089/dia.2021.0007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0003">
<span class="label">3.</span><cite>
Ajjan R. A., Battelino T., Cos X., et al., “Continuous Glucose Monitoring for the Routine Care of Type 2 Diabetes Mellitus,” Nature Reviews. Endocrinology
20, no. 7 (2024): 426–440.</cite> [<a href="https://doi.org/10.1038/s41574-024-00973-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38589493/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Endocrinology&amp;title=Continuous%20Glucose%20Monitoring%20for%20the%20Routine%20Care%20of%20Type%202%20Diabetes%20Mellitus&amp;author=R.%20A.%20Ajjan&amp;author=T.%20Battelino&amp;author=X.%20Cos&amp;volume=20&amp;issue=7&amp;publication_year=2024&amp;pages=426-440&amp;pmid=38589493&amp;doi=10.1038/s41574-024-00973-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0004">
<span class="label">4.</span><cite>
American Diabetes Association Professional Practice Committee
, “7. Diabetes Technology: Standards of Care in Diabetes‐2025,” Diabetes Care
48, no. Supplement_1 (2025): S146–S166.
</cite> [<a href="https://doi.org/10.2337/dc25-S007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11635043/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39651978/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=7.%20Diabetes%20Technology:%20Standards%20of%20Care%20in%20Diabetes%E2%80%902025&amp;volume=48&amp;issue=Supplement_1&amp;publication_year=2025&amp;pages=S146-S166&amp;pmid=39651978&amp;doi=10.2337/dc25-S007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0005">
<span class="label">5.</span><cite>
Edelman S. V., Cavaiola T. S., Boeder S., and Pettus J., “Utilizing Continuous Glucose Monitoring in Primary Care Practice: What the Numbers Mean,” Primary Care Diabetes
15, no. 2 (2021): 199–207.
</cite> [<a href="https://doi.org/10.1016/j.pcd.2020.10.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33257275/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Primary%20Care%20Diabetes&amp;title=Utilizing%20Continuous%20Glucose%20Monitoring%20in%20Primary%20Care%20Practice:%20What%20the%20Numbers%20Mean&amp;author=S.%20V.%20Edelman&amp;author=T.%20S.%20Cavaiola&amp;author=S.%20Boeder&amp;author=J.%20Pettus&amp;volume=15&amp;issue=2&amp;publication_year=2021&amp;pages=199-207&amp;pmid=33257275&amp;doi=10.1016/j.pcd.2020.10.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0006">
<span class="label">6.</span><cite>
Battelino T., Alexander C. M., Amiel S. A., et al., “Continuous Glucose Monitoring and Metrics for Clinical Trials: An International Consensus Statement,” Lancet Diabetes and Endocrinology
11, no. 1 (2023): 42–57.
</cite> [<a href="https://doi.org/10.1016/S2213-8587(22)00319-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36493795/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Diabetes%20and%20Endocrinology&amp;title=Continuous%20Glucose%20Monitoring%20and%20Metrics%20for%20Clinical%20Trials:%20An%20International%20Consensus%20Statement&amp;author=T.%20Battelino&amp;author=C.%20M.%20Alexander&amp;author=S.%20A.%20Amiel&amp;volume=11&amp;issue=1&amp;publication_year=2023&amp;pages=42-57&amp;pmid=36493795&amp;doi=10.1016/S2213-8587(22)00319-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0007">
<span class="label">7.</span><cite>
Akturk H. K., Dowd R., Shankar K., and Derdzinski M., “Real‐World Evidence and Glycemic Improvement Using Dexcom G6 Features,” Diabetes Technology &amp; Therapeutics
23, no. S1 (2021): S21–S26.
</cite> [<a href="https://doi.org/10.1089/dia.2020.0654" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7957382/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33434439/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Technology%20&amp;%20Therapeutics&amp;title=Real%E2%80%90World%20Evidence%20and%20Glycemic%20Improvement%20Using%20Dexcom%20G6%20Features&amp;author=H.%20K.%20Akturk&amp;author=R.%20Dowd&amp;author=K.%20Shankar&amp;author=M.%20Derdzinski&amp;volume=23&amp;issue=S1&amp;publication_year=2021&amp;pages=S21-S26&amp;pmid=33434439&amp;doi=10.1089/dia.2020.0654&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0008">
<span class="label">8.</span><cite>
Beck R. W., Riddlesworth T. D., Ruedy K., et al., “Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial,” Annals of Internal Medicine
167, no. 6 (2017): 365–374.
</cite> [<a href="https://doi.org/10.7326/M16-2855" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28828487/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Internal%20Medicine&amp;title=Continuous%20Glucose%20Monitoring%20Versus%20Usual%20Care%20in%20Patients%20With%20Type%202%20Diabetes%20Receiving%20Multiple%20Daily%20Insulin%20Injections:%20A%20Randomized%20Trial&amp;author=R.%20W.%20Beck&amp;author=T.%20D.%20Riddlesworth&amp;author=K.%20Ruedy&amp;volume=167&amp;issue=6&amp;publication_year=2017&amp;pages=365-374&amp;pmid=28828487&amp;doi=10.7326/M16-2855&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0009">
<span class="label">9.</span><cite>
Shields S., Norman G. J., Thomas R., and Ciemins E. L., “HbA1c Improvements After Initiation of Real‐Time Continuous Glucose Monitoring in Primary Care Patients With Type 2 Diabetes,” Journal of Diabetes Science and Technology
17, no. 5 (2023): 1423–1424.
</cite> [<a href="https://doi.org/10.1177/19322968231171176" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10563531/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37165659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Diabetes%20Science%20and%20Technology&amp;title=HbA1c%20Improvements%20After%20Initiation%20of%20Real%E2%80%90Time%20Continuous%20Glucose%20Monitoring%20in%20Primary%20Care%20Patients%20With%20Type%202%20Diabetes&amp;author=S.%20Shields&amp;author=G.%20J.%20Norman&amp;author=R.%20Thomas&amp;author=E.%20L.%20Ciemins&amp;volume=17&amp;issue=5&amp;publication_year=2023&amp;pages=1423-1424&amp;pmid=37165659&amp;doi=10.1177/19322968231171176&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0010">
<span class="label">10.</span><cite>
Martens T., Beck R. W., Bailey R., et al., “Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial,” JAMA
325, no. 22 (2021): 2262–2272.
</cite> [<a href="https://doi.org/10.1001/jama.2021.7444" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8173473/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34077499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Effect%20of%20Continuous%20Glucose%20Monitoring%20on%20Glycemic%20Control%20in%20Patients%20With%20Type%202%20Diabetes%20Treated%20With%20Basal%20Insulin:%20A%20Randomized%20Clinical%20Trial&amp;author=T.%20Martens&amp;author=R.%20W.%20Beck&amp;author=R.%20Bailey&amp;volume=325&amp;issue=22&amp;publication_year=2021&amp;pages=2262-2272&amp;pmid=34077499&amp;doi=10.1001/jama.2021.7444&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0011">
<span class="label">11.</span><cite>

E. E.
Wright, Jr.
, Kerr M. S. D., Reyes I. J., Nabutovsky Y., and Miller E., “Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy,” Diabetes Spectrum: A Publication of the American Diabetes Association
34, no. 2 (2021): 184–189.
</cite> [<a href="https://doi.org/10.2337/ds20-0069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8178717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34149259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Spectrum:%20A%20Publication%20of%20the%20American%20Diabetes%20Association&amp;title=Use%20of%20Flash%20Continuous%20Glucose%20Monitoring%20Is%20Associated%20With%20A1C%20Reduction%20in%20People%20With%20Type%202%20Diabetes%20Treated%20With%20Basal%20Insulin%20or%20Noninsulin%20Therapy&amp;author=E.%20E.%20Wright&amp;author=M.%20S.%20D.%20Kerr&amp;author=I.%20J.%20Reyes&amp;author=Y.%20Nabutovsky&amp;author=E.%20Miller&amp;volume=34&amp;issue=2&amp;publication_year=2021&amp;pages=184-189&amp;pmid=34149259&amp;doi=10.2337/ds20-0069&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0012">
<span class="label">12.</span><cite>
Grace T. and Salyer J., “Use of Real‐Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated With Less Intensive Therapy,” Diabetes Technology &amp; Therapeutics
24, no. 1 (2022): 26–31.
</cite> [<a href="https://doi.org/10.1089/dia.2021.0212" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8783626/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34524013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Technology%20&amp;%20Therapeutics&amp;title=Use%20of%20Real%E2%80%90Time%20Continuous%20Glucose%20Monitoring%20Improves%20Glycemic%20Control%20and%20Other%20Clinical%20Outcomes%20in%20Type%202%20Diabetes%20Patients%20Treated%20With%20Less%20Intensive%20Therapy&amp;author=T.%20Grace&amp;author=J.%20Salyer&amp;volume=24&amp;issue=1&amp;publication_year=2022&amp;pages=26-31&amp;pmid=34524013&amp;doi=10.1089/dia.2021.0212&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0013">
<span class="label">13.</span><cite>
Aronson R., Brown R. E., Chu L., et al., “IMpact of Flash Glucose Monitoring in pEople With Type 2 Diabetes Inadequately Controlled With Non‐Insulin Antihyperglycaemic ThErapy (IMMEDIATE): A Randomized Controlled Trial,” Diabetes, Obesity &amp; Metabolism
25, no. 4 (2023): 1024–1031.</cite> [<a href="https://doi.org/10.1111/dom.14949" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36546594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes,%20Obesity%20&amp;%20Metabolism&amp;title=IMpact%20of%20Flash%20Glucose%20Monitoring%20in%20pEople%20With%20Type%202%20Diabetes%20Inadequately%20Controlled%20With%20Non%E2%80%90Insulin%20Antihyperglycaemic%20ThErapy%20(IMMEDIATE):%20A%20Randomized%20Controlled%20Trial&amp;author=R.%20Aronson&amp;author=R.%20E.%20Brown&amp;author=L.%20Chu&amp;volume=25&amp;issue=4&amp;publication_year=2023&amp;pages=1024-1031&amp;pmid=36546594&amp;doi=10.1111/dom.14949&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0014">
<span class="label">14.</span><cite>
U.S. Department of Health and Human Services
, “Guidance Regarding Methods for De‐Identification of Protected Health Information in Accordance With the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule,” (2015).</cite>
</li>
<li id="edm270089-bib-0015">
<span class="label">15.</span><cite>
Price D. A., Deng Q., Kipnes M., and Beck S. E., “Episodic Real‐Time CGM Use in Adults With Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial,” Diabetes Ther
12, no. 7 (2021): 2089–2099.
</cite> [<a href="https://doi.org/10.1007/s13300-021-01086-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8177263/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34089138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Ther&amp;title=Episodic%20Real%E2%80%90Time%20CGM%20Use%20in%20Adults%20With%20Type%202%20Diabetes:%20Results%20of%20a%20Pilot%20Randomized%20Controlled%20Trial&amp;author=D.%20A.%20Price&amp;author=Q.%20Deng&amp;author=M.%20Kipnes&amp;author=S.%20E.%20Beck&amp;volume=12&amp;issue=7&amp;publication_year=2021&amp;pages=2089-2099&amp;pmid=34089138&amp;doi=10.1007/s13300-021-01086-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0016">
<span class="label">16.</span><cite>
Nemlekar P. M., Hannah K. L., and Norman G. J., “Association Between Change in A1C and Use of Professional Continuous Glucose Monitoring in Adults With Type 2 Diabetes on Noninsulin Therapies: A Real‐World Evidence Study,” Clinical Diabetes
41, no. 3 (2023): 359–366.
</cite> [<a href="https://doi.org/10.2337/cd22-0080" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10338284/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37456087/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Diabetes&amp;title=Association%20Between%20Change%20in%20A1C%20and%20Use%20of%20Professional%20Continuous%20Glucose%20Monitoring%20in%20Adults%20With%20Type%202%20Diabetes%20on%20Noninsulin%20Therapies:%20A%20Real%E2%80%90World%20Evidence%20Study&amp;author=P.%20M.%20Nemlekar&amp;author=K.%20L.%20Hannah&amp;author=G.%20J.%20Norman&amp;volume=41&amp;issue=3&amp;publication_year=2023&amp;pages=359-366&amp;pmid=37456087&amp;doi=10.2337/cd22-0080&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0017">
<span class="label">17.</span><cite>
Chronic Conditions Warehouse
, “30 CCW Chronic Conditions Algorithms,” Chronic Conditions Data Warehouse (2025), <a href="https://www2.ccwdata.org/documents/10280/19139421/chr-chronic-condition-algorithms.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www2.ccwdata.org/documents/10280/19139421/chr‐chronic‐condition‐algorithms.pdf</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Chronic%20Conditions%20Data%20Warehouse&amp;title=30%20CCW%20Chronic%20Conditions%20Algorithms&amp;publication_year=2025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0018">
<span class="label">18.</span><cite>
Almigbal T. H., Alzarah S. A., Aljanoubi F. A., et al., “Clinical Inertia in the Management of Type 2 Diabetes Mellitus: A Systematic Review,” Medicina (Kaunas, Lithuania)
59, no. 1 (2023): 182.
</cite> [<a href="https://doi.org/10.3390/medicina59010182" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9866102/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36676805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medicina%20(Kaunas,%20Lithuania)&amp;title=Clinical%20Inertia%20in%20the%20Management%20of%20Type%202%20Diabetes%20Mellitus:%20A%20Systematic%20Review&amp;author=T.%20H.%20Almigbal&amp;author=S.%20A.%20Alzarah&amp;author=F.%20A.%20Aljanoubi&amp;volume=59&amp;issue=1&amp;publication_year=2023&amp;pages=182&amp;pmid=36676805&amp;doi=10.3390/medicina59010182&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0019">
<span class="label">19.</span><cite>
Martens T. W. and Parkin C. G., “How Use of Continuous Glucose Monitoring Can Address Therapeutic Inertia in Primary Care,” Postgraduate Medicine
134, no. 6 (2022): 576–588.
</cite> [<a href="https://doi.org/10.1080/00325481.2022.2080419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35584802/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Postgraduate%20Medicine&amp;title=How%20Use%20of%20Continuous%20Glucose%20Monitoring%20Can%20Address%20Therapeutic%20Inertia%20in%20Primary%20Care&amp;author=T.%20W.%20Martens&amp;author=C.%20G.%20Parkin&amp;volume=134&amp;issue=6&amp;publication_year=2022&amp;pages=576-588&amp;pmid=35584802&amp;doi=10.1080/00325481.2022.2080419&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0020">
<span class="label">20.</span><cite>
Batalha A., Ponciano I. C., Chaves G., Felicio D. C., Britto R. R., and da Silva L. P., “Behavior Change Interventions in Patients With Type 2 Diabetes: A Systematic Review of the Effects on Self‐Management and A1c,” Journal of Diabetes &amp; Metabolic Disorders
20, no. 2 (2021): 1815–1836.
</cite> [<a href="https://doi.org/10.1007/s40200-021-00846-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8630317/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34900827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Diabetes%20&amp;%20Metabolic%20Disorders&amp;title=Behavior%20Change%20Interventions%20in%20Patients%20With%20Type%202%20Diabetes:%20A%20Systematic%20Review%20of%20the%20Effects%20on%20Self%E2%80%90Management%20and%20A1c&amp;author=A.%20Batalha&amp;author=I.%20C.%20Ponciano&amp;author=G.%20Chaves&amp;author=D.%20C.%20Felicio&amp;author=R.%20R.%20Britto&amp;volume=20&amp;issue=2&amp;publication_year=2021&amp;pages=1815-1836&amp;pmid=34900827&amp;doi=10.1007/s40200-021-00846-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0021">
<span class="label">21.</span><cite>
Ehrhardt N. and Al Z. E., “Continuous Glucose Monitoring as a Behavior Modification Tool,” Clinical Diabetes
38, no. 2 (2020): 126–131.
</cite> [<a href="https://doi.org/10.2337/cd19-0037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7164990/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32327884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Diabetes&amp;title=Continuous%20Glucose%20Monitoring%20as%20a%20Behavior%20Modification%20Tool&amp;author=N.%20Ehrhardt&amp;author=Z.%20E.%20Al&amp;volume=38&amp;issue=2&amp;publication_year=2020&amp;pages=126-131&amp;pmid=32327884&amp;doi=10.2337/cd19-0037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0022">
<span class="label">22.</span><cite>
Clark T. L., Polonsky W. H., and Soriano E. C., “The Potential Impact of Continuous Glucose Monitoring Use on Diabetes‐Related Attitudes and Behaviors in Adults With Type 2 Diabetes: A Qualitative Investigation of the Patient Experience,” Diabetes Technology &amp; Therapeutics
26, no. 10 (2024): 700–708.
</cite> [<a href="https://doi.org/10.1089/dia.2023.0612" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38526557/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Technology%20&amp;%20Therapeutics&amp;title=The%20Potential%20Impact%20of%20Continuous%20Glucose%20Monitoring%20Use%20on%20Diabetes%E2%80%90Related%20Attitudes%20and%20Behaviors%20in%20Adults%20With%20Type%202%20Diabetes:%20A%20Qualitative%20Investigation%20of%20the%20Patient%20Experience&amp;author=T.%20L.%20Clark&amp;author=W.%20H.%20Polonsky&amp;author=E.%20C.%20Soriano&amp;volume=26&amp;issue=10&amp;publication_year=2024&amp;pages=700-708&amp;pmid=38526557&amp;doi=10.1089/dia.2023.0612&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0023">
<span class="label">23.</span><cite>
Beck R. W., Connor C. G., Mullen D. M., Wesley D. M., and Bergenstal R. M., “The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can be Misleading,” Diabetes Care
40, no. 8 (2017): 994–999.
</cite> [<a href="https://doi.org/10.2337/dc17-0636" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5521971/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28733374/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=The%20Fallacy%20of%20Average:%20How%20Using%20HbA1c%20Alone%20to%20Assess%20Glycemic%20Control%20Can%20be%20Misleading&amp;author=R.%20W.%20Beck&amp;author=C.%20G.%20Connor&amp;author=D.%20M.%20Mullen&amp;author=D.%20M.%20Wesley&amp;author=R.%20M.%20Bergenstal&amp;volume=40&amp;issue=8&amp;publication_year=2017&amp;pages=994-999&amp;pmid=28733374&amp;doi=10.2337/dc17-0636&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0024">
<span class="label">24.</span><cite>
Wright E. E., Roberts G. J., Chuang J. S., Nabutovsky Y., Virdi N., and Miller E., “Initiating GLP‐1 Therapy in Combination With FreeStyle Libre Provides Greater Benefit Compared With GLP‐1 Therapy Alone,” Diabetes Technology &amp; Therapeutics
26, no. 10 (2024): 754–762.
</cite> [<a href="https://doi.org/10.1089/dia.2024.0015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38669474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Technology%20&amp;%20Therapeutics&amp;title=Initiating%20GLP%E2%80%901%20Therapy%20in%20Combination%20With%20FreeStyle%20Libre%20Provides%20Greater%20Benefit%20Compared%20With%20GLP%E2%80%901%20Therapy%20Alone&amp;author=E.%20E.%20Wright&amp;author=G.%20J.%20Roberts&amp;author=J.%20S.%20Chuang&amp;author=Y.%20Nabutovsky&amp;author=N.%20Virdi&amp;volume=26&amp;issue=10&amp;publication_year=2024&amp;pages=754-762&amp;pmid=38669474&amp;doi=10.1089/dia.2024.0015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0025">
<span class="label">25.</span><cite>
Miller E., Chuang J. S., Roberts G. J., Nabutovsky Y., Virdi N., and 
E. E.
Wright, Jr.
, “Association of Changes in A1C Following Continuous Glucose Monitoring Acquisition in People With Sub‐Optimally Treated Type 2 Diabetes Taking GLP‐1 RA Therapy,” Diabetes Ther
15, no. 9 (2024): 2027–2038.
</cite> [<a href="https://doi.org/10.1007/s13300-024-01619-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11330431/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39008235/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Ther&amp;title=Association%20of%20Changes%20in%20A1C%20Following%20Continuous%20Glucose%20Monitoring%20Acquisition%20in%20People%20With%20Sub%E2%80%90Optimally%20Treated%20Type%202%20Diabetes%20Taking%20GLP%E2%80%901%20RA%20Therapy&amp;author=E.%20Miller&amp;author=J.%20S.%20Chuang&amp;author=G.%20J.%20Roberts&amp;author=Y.%20Nabutovsky&amp;author=N.%20Virdi&amp;volume=15&amp;issue=9&amp;publication_year=2024&amp;pages=2027-2038&amp;pmid=39008235&amp;doi=10.1007/s13300-024-01619-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0026">
<span class="label">26.</span><cite>
Parsiani R., Grace T., Green C. R., Castle J. R., and Wilson L. M., “Continuous Glucose Monitoring Guides Glucagon‐Like Peptide 1‐Based Therapy Use and Optimization in People with Type 2 Diabetes,” Journal of Family Medicine and Primary Care
14 (2025): 790–795, 10.4103/jfmpc.jfmpc_773_24.</cite> [<a href="https://doi.org/10.4103/jfmpc.jfmpc_773_24" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11922371/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40115561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Family%20Medicine%20and%20Primary%20Care&amp;title=Continuous%20Glucose%20Monitoring%20Guides%20Glucagon%E2%80%90Like%20Peptide%201%E2%80%90Based%20Therapy%20Use%20and%20Optimization%20in%20People%20with%20Type%202%20Diabetes&amp;author=R.%20Parsiani&amp;author=T.%20Grace&amp;author=C.%20R.%20Green&amp;author=J.%20R.%20Castle&amp;author=L.%20M.%20Wilson&amp;volume=14&amp;publication_year=2025&amp;pages=790-795&amp;pmid=40115561&amp;doi=10.4103/jfmpc.jfmpc_773_24&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0027">
<span class="label">27.</span><cite>
Ehrhardt N. M., Aroda V. R., Galindo R. J., Peters A. L., and Shubrook J. H., “Use of Continuous Glucose Monitoring and Glucagon‐Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin‐Treated People With Type 2 Diabetes: A Case Series and Expert Opinion,” Clinical Diabetes
42, no. 2 (2024): 341–350.
</cite> [<a href="https://doi.org/10.2337/cd23-0047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11040021/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38666194/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Diabetes&amp;title=Use%20of%20Continuous%20Glucose%20Monitoring%20and%20Glucagon%E2%80%90Like%20Peptide%201%20Receptor%20Agonist%20Therapy%20to%20Achieve%20Individualized%20Treatment%20Goals%20in%20Insulin%E2%80%90Treated%20People%20With%20Type%202%20Diabetes:%20A%20Case%20Series%20and%20Expert%20Opinion&amp;author=N.%20M.%20Ehrhardt&amp;author=V.%20R.%20Aroda&amp;author=R.%20J.%20Galindo&amp;author=A.%20L.%20Peters&amp;author=J.%20H.%20Shubrook&amp;volume=42&amp;issue=2&amp;publication_year=2024&amp;pages=341-350&amp;pmid=38666194&amp;doi=10.2337/cd23-0047&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0028">
<span class="label">28.</span><cite>
Alkabbani W., Cromer S. J., Kim D. H., et al., “Overall Uptake and Racial, Ethnic, and Socioeconomic Disparities in the Use of Continuous Glucose Monitoring Devices Among Insulin‐Treated Older Adults With Type 2 Diabetes,” Diabetes Care
48 (2025): 1377–1385.
</cite> [<a href="https://doi.org/10.2337/dca25-0006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40445849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Overall%20Uptake%20and%20Racial,%20Ethnic,%20and%20Socioeconomic%20Disparities%20in%20the%20Use%20of%20Continuous%20Glucose%20Monitoring%20Devices%20Among%20Insulin%E2%80%90Treated%20Older%20Adults%20With%20Type%202%20Diabetes&amp;author=W.%20Alkabbani&amp;author=S.%20J.%20Cromer&amp;author=D.%20H.%20Kim&amp;volume=48&amp;publication_year=2025&amp;pages=1377-1385&amp;pmid=40445849&amp;doi=10.2337/dca25-0006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0029">
<span class="label">29.</span><cite>
Isaacs D., Bellini N. J., Biba U., Cai A., and Close K. L., “Health Care Disparities in Use of Continuous Glucose Monitoring,” Diabetes Technology &amp; Therapeutics
23, no. S3 (2021): S81–S87.
</cite> [<a href="https://doi.org/10.1089/dia.2021.0268" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34546086/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Technology%20&amp;%20Therapeutics&amp;title=Health%20Care%20Disparities%20in%20Use%20of%20Continuous%20Glucose%20Monitoring&amp;author=D.%20Isaacs&amp;author=N.%20J.%20Bellini&amp;author=U.%20Biba&amp;author=A.%20Cai&amp;author=K.%20L.%20Close&amp;volume=23&amp;issue=S3&amp;publication_year=2021&amp;pages=S81-S87&amp;pmid=34546086&amp;doi=10.1089/dia.2021.0268&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0030">
<span class="label">30.</span><cite>
Wallia A., Agarwal S., Owen A. L., et al., “Disparities in Continuous Glucose Monitoring Among Patients Receiving Care in Federally Qualified Health Centers,” JAMA Network Open
7, no. 11 (2024): e2445316.
</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2024.45316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11584923/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39576644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Network%20Open&amp;title=Disparities%20in%20Continuous%20Glucose%20Monitoring%20Among%20Patients%20Receiving%20Care%20in%20Federally%20Qualified%20Health%20Centers&amp;author=A.%20Wallia&amp;author=S.%20Agarwal&amp;author=A.%20L.%20Owen&amp;volume=7&amp;issue=11&amp;publication_year=2024&amp;pages=e2445316&amp;pmid=39576644&amp;doi=10.1001/jamanetworkopen.2024.45316&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0031">
<span class="label">31.</span><cite>
Saeed Z. I., Ostrominski J. W., and Aroda V. R., “Polypharmacy in Type 2 Diabetes: Appropriate or Cause for Concern?,” Diabetes Care
47, no. 12 (2024): 2104–2106.
</cite> [<a href="https://doi.org/10.2337/dci24-0035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39602592/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Polypharmacy%20in%20Type%202%20Diabetes:%20Appropriate%20or%20Cause%20for%20Concern?&amp;author=Z.%20I.%20Saeed&amp;author=J.%20W.%20Ostrominski&amp;author=V.%20R.%20Aroda&amp;volume=47&amp;issue=12&amp;publication_year=2024&amp;pages=2104-2106&amp;pmid=39602592&amp;doi=10.2337/dci24-0035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0032">
<span class="label">32.</span><cite>
Karagiannis T., Paschos P., Paletas K., Matthews D. R., and Tsapas A., “Dipeptidyl Peptidase‐4 Inhibitors for Treatment of Type 2 Diabetes Mellitus in the Clinical Setting: Systematic Review and Meta‐Analysis,” BMJ
344 (2012): e1369.
</cite> [<a href="https://doi.org/10.1136/bmj.e1369" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22411919/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Dipeptidyl%20Peptidase%E2%80%904%20Inhibitors%20for%20Treatment%20of%20Type%202%20Diabetes%20Mellitus%20in%20the%20Clinical%20Setting:%20Systematic%20Review%20and%20Meta%E2%80%90Analysis&amp;author=T.%20Karagiannis&amp;author=P.%20Paschos&amp;author=K.%20Paletas&amp;author=D.%20R.%20Matthews&amp;author=A.%20Tsapas&amp;volume=344&amp;publication_year=2012&amp;pages=e1369&amp;pmid=22411919&amp;doi=10.1136/bmj.e1369&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0033">
<span class="label">33.</span><cite>
HealthDay
, “Diabetes Med Ozempic in Short Supply as Americans Use It for Weight Loss,” U.S. News &amp; World Report (2025), <a href="https://www.usnews.com/news/health-news/articles/2022-12-21/diabetes-med-ozempic-in-short-supply-as-americans-use-it-for-weight-loss" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.usnews.com/news/health‐news/articles/2022‐12‐21/diabetes‐med‐ozempic‐in‐short‐supply‐as‐americans‐use‐it‐for‐weight‐loss</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=U.S.%20News%20&amp;%20World%20Report&amp;title=Diabetes%20Med%20Ozempic%20in%20Short%20Supply%20as%20Americans%20Use%20It%20for%20Weight%20Loss&amp;publication_year=2025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0034">
<span class="label">34.</span><cite>
Nemlekar P. M., Hannah K. L., Green C. R., and Norman G. J., “Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People With Type 1 Diabetes or Type 2 Diabetes Treated With Intensive Insulin Therapy,” Diabetes Ther
15, no. 3 (2024): 639–648.
</cite> [<a href="https://doi.org/10.1007/s13300-023-01529-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10942933/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38289464/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Ther&amp;title=Association%20Between%20Adherence,%20A1C%20Improvement,%20and%20Type%20of%20Continuous%20Glucose%20Monitoring%20System%20in%20People%20With%20Type%201%20Diabetes%20or%20Type%202%20Diabetes%20Treated%20With%20Intensive%20Insulin%20Therapy&amp;author=P.%20M.%20Nemlekar&amp;author=K.%20L.%20Hannah&amp;author=C.%20R.%20Green&amp;author=G.%20J.%20Norman&amp;volume=15&amp;issue=3&amp;publication_year=2024&amp;pages=639-648&amp;pmid=38289464&amp;doi=10.1007/s13300-023-01529-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270089-bib-0035">
<span class="label">35.</span><cite>
Sherifali D., Nerenberg K., Pullenayegum E., Cheng J. E., and Gerstein H. C., “The Effect of Oral Antidiabetic Agents on A1C Levels: A Systematic Review and Meta‐Analysis,” Diabetes Care
33, no. 8 (2010): 1859–1864.
</cite> [<a href="https://doi.org/10.2337/dc09-1727" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2909079/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20484130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=The%20Effect%20of%20Oral%20Antidiabetic%20Agents%20on%20A1C%20Levels:%20A%20Systematic%20Review%20and%20Meta%E2%80%90Analysis&amp;author=D.%20Sherifali&amp;author=K.%20Nerenberg&amp;author=E.%20Pullenayegum&amp;author=J.%20E.%20Cheng&amp;author=H.%20C.%20Gerstein&amp;volume=33&amp;issue=8&amp;publication_year=2010&amp;pages=1859-1864&amp;pmid=20484130&amp;doi=10.2337/dc09-1727&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
<strong>Appendix S1:</strong> National drug codes for anti‐diabetes medications.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12375899/bin/EDM2-8-e70089-s002.xlsx" data-ga-action="click_feat_suppl" class="usa-link">EDM2-8-e70089-s002.xlsx</a><sup> (138.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><p>
<strong>Figure S1:</strong> Change in A1c by CGM use and use of anti‐diabetes medication.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12375899/bin/EDM2-8-e70089-s003.pdf" data-ga-action="click_feat_suppl" class="usa-link">EDM2-8-e70089-s003.pdf</a><sup> (8.6KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<p>
<strong>Table S1:</strong> National drug codes (NDCs) and healthcare common procedure coding system (HCPCS) codes for CGM systems included in the analysis.</p>
<p>
<strong>Table S2:</strong> Linear regression model including the two‐way interaction term for CGM use and sulfonylurea use.</p>
<p>
<strong>Table S3:</strong> Linear regression model including the two‐way interaction term for CGM use and DPP‐4 inhibitor use.</p>
<p>
<strong>Table S4:</strong> Linear regression model including the two‐way interaction term for CGM use and GLP‐1 RA use.</p>
<p>
<strong>Table S5:</strong> Linear regression model including the two‐way interaction term for CGM use and metformin use.</p>
<p>
<strong>Table S6:</strong> Linear regression model including the two‐way interaction term for CGM use and SGLT2 inhibitor use.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12375899/bin/EDM2-8-e70089-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">EDM2-8-e70089-s001.docx</a><sup> (51.3KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data that support the findings of this study are available from Optum. Restrictions apply to the availability of these data, which were used under license for this study. Data are available from the authors with the permission of Optum.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Endocrinology, Diabetes &amp; Metabolism are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/edm2.70089"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/EDM2-8-e70089.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (260.3 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12375899/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12375899/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12375899%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375899/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12375899/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12375899/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12375899/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12375899/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12375899/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="I64xGcbzECJECEdOL3xEMIobBUJ6nC9OiTqAB43CRvnpJSuHPhxJfZAtvhJMVvwP">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
